LENZ
LENZ Therapeutics Inc
3.60$
-5.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
LENZ Therapeutics Inc (LENZ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -39 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.0 | -5.3 | -8.1 | -14 | -15 | -16 | -21 | -22 | -22 | -7.5 | -13 | -5.2 | -13 | -21 | -24 | -16 | -11 | -9.1 | -16 | -12 | -8.6 | -33 | -34 | -39 | -114 | |
| 0.0 | 0.1 | 0.1 | 0.1 | 0.6 | 1.9 | 1.9 | 2.1 | 2.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | -3.3 | 0.1 | 0.1 | -3.0 | |
| – | – | – | – | – | – | – | 0.4 | 0.4 | 0.4 | 0.1 | 0.2 | 0.5 | 0.5 | 0.9 | 1.6 | 2.2 | 1.6 | 2.6 | 2.8 | 3.5 | 3.7 | 4.3 | 4.5 | 16 | |
| 0.3 | 0.1 | 0.2 | 1.6 | -3.8 | -0.5 | -0.7 | -1.6 | -2.4 | 1.6 | -0.3 | 1.8 | 5.7 | 3.0 | -9.0 | -6.2 | -1.2 | 3.3 | -3.0 | 1.4 | 5.3 | -0.5 | 3.4 | -11 | -3.1 | |
| 0.4 | 0.6 | 0.4 | 0.8 | 3.6 | 1.0 | 3.3 | 1.4 | 0.9 | 0.0 | 0.0 | 0.4 | 4.8 | 0.1 | 0.0 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.4 | 0.0 | 0.0 | 0.0 | 0.5 | |
| -0.4 | -0.6 | -0.4 | -0.8 | -3.6 | -1.0 | -171 | -88 | 3.5 | 0.0 | 0.0 | -70 | -18 | 15 | 18 | -98 | -62 | -12 | 19 | -0.4 | -4.3 | -90 | 33 | 38 | -23 | |
| – | – | – | – | – | – | -0.1 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | 0.2 | – | – | – | – | |
| 15 | 15 | 166 | 219 | 32 | 0.3 | 0.4 | 0.4 | -0.1 | 20 | 83 | 83 | -0.6 | -1.9 | 171 | -2.1 | 30 | 0.1 | 0.0 | 26 | 0.6 | 123 | 0.0 | 0.4 | 124 | |
| – | 20 | 157 | 205 | 13 | -18 | -192 | -110 | -19 | 13 | 70 | 59 | -32 | -7.7 | 165 | -116 | -43 | -21 | 2.9 | 15 | -12 | -0.2 | -0.4 | -0.6 | -14 | |
| -1.3 | -5.9 | -8.4 | -15 | -19 | -17 | -25 | -23 | -23 | -7.5 | -13 | -4.9 | -13 | -21 | -24 | -16 | -11 | -9.2 | -16 | -12 | -9.0 | -33 | -34 | -39 | -114 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.